Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is... see more

Bullboard (CSE:RVV)

View:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Post by RBLCommon Oct 31, 2024 8:21am

NEWS: Revive Therapeutics Provides Update on Research...

Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure READ MORE  
54
Comment by hk1966on Jun 26, 2024 10:13pm

RE: June 10, 2024 (GLOBE NEWSWIRE)

AKA go pound salt you'll never get approved 
192
Discussion
Post by G1945Von Jun 11, 2024 5:15am

June 10, 2024 (GLOBE NEWSWIRE)

Revive Therapeutics Provides Update From FDA Meeting for Long COVID Diagnostic Product "The FDA has determined that the Product should follow the De Novo regulatory pathway, and the Company ...more  
505
Discussion
Post by adoubleyouon May 03, 2024 6:52pm

Next week's live was canceled per ftmig Twitter

Rvv posted on their handle for X that they will schedule something soon on a different platform.  
208
Post by cool888on May 02, 2024 7:57pm

Rescheduled - Wednesday May 8th at 2pm ET.

https://twitter.com/FTMInvest/status/1786167849834127412  
185
Post by adoubleyouon May 02, 2024 7:55pm

Mike frank to go live Wednesday may 8th at 7pm et

Apologies for our failed x space earlier with Revive_RVV  RVV CEO Michael Frank. For all that were tuned in we hope you weren't too inconvenienced and we hope to make it up to those ...more  
228
Comment by G1945Von May 02, 2024 3:38pm

RE:An Overview & Q&A with CEO Michael Frank May 2nd 4pm

Is the 4 PM EDT Q&A strictly for X subscribers? G1945V
123
Discussion
Post by Tesla888on Apr 29, 2024 2:45pm

An Overview & Q&A with CEO Michael Frank May 2nd 4pm

Link - https://twitter.com/ftminvest/status/1784693118308122941?s=46&t=LsRlg0oC9EbPON1oBKpUbw
213
Discussion
Post by Tesla888on Apr 18, 2024 8:19am

$RVV - FDA mtg June 7th

https://ca.finance.yahoo.com/news/revive-therapeutics-announces-fda-acceptance-110000050.html
196
Post by Tesla888on Apr 02, 2024 8:36am

$RVV News

https://ca.finance.yahoo.com/news/revive-therapeutics-provides-psilocybin-clinical-113000679.html
198
Post by Tesla888on Mar 19, 2024 9:01pm

$RVV - we get hour money back ? Hope so !!

https://ca.finance.yahoo.com/news/revive-therapeutics-submit-type-c-110000338.html  
304
Discussion
Post by Betteryear2on Mar 12, 2024 8:48am

Revive Therapeutics Provides Corporate Update

TORONTO, March 12, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research ...more  
269
Post by Betteryear2on Jan 10, 2024 11:26am

Revive Therapeutics Successfully Completes Development

TORONTO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and ...more  
417
Post by Betteryear2on Dec 18, 2023 8:40am

Revive Therapeutics Collaborates

TORONTO, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and ...more  
341
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next